GSK

GSK video brief & financials: CEO reports a ‘strong start’ for 2023

Posted by WRAL TechWire | Apr 26, 2023

Watch GSK CEO Emma Walmsley’s video update on the drug giant’s quarterly financials and catch Reuters’ coverage: GSK stays strong as healthy sales beat expectations.

GSK faces strike from union in UK involving hundreds of workers

Posted by WRAL TechWire | Apr 19, 2023

Hundreds of workers at a union representing GSK workers in the United Kingdom have voted to strike over pay, according to Reuters news service.

GSK to buy drug firm that has candidate to combat 900-a-day cough

Posted by WRAL TechWire | Apr 18, 2023

GSK is buying Canada-based drug maker Bellus Health for some $2 billion in a bid to expand its respiratory drug pipeline. Bellus has a candidate to treat refractory chronic cough, or RCC, in stage 3 clinical trials.

GSK news: Drug giant tops new gender equality index

Posted by WRAL TechWire | Feb 6, 2023

GSK tops a new list for gender equality among the FTSE 100 businesses, FTSE standing for Financial Times Stock Exchange.

How well is GSK really doing? CEO Walmsley is upbeat but analysts have concerns

Posted by WRAL TechWire | Feb 1, 2023

Drug giant GSK reported early Wednesday profits and revenues which beat expectations, and CEO Emma Walmsley delivered an upbeat summary of company performance. But some analysts are concerned about its pipeline.

GSK expansion news: Drug giant is adding R&D space in Mass.

Posted by WRAL TechWire | Jan 11, 2023

Drug giant GSK, which employs thousands of people across the Triangle, is expanding its research and development footprint in the U.S.

GSK news: Drug giant is looking for acquisitions entering 2023

Posted by WRAL TechWire | Dec 30, 2022

GSK is on the prowl for more acquisitions in 2023, a senior executive tells The Financial Times.

GSK picks downtown London for new corporate headquarters

Posted by WRAL TechWire | Dec 12, 2022

“As a global biopharma company, we are proud to call London our home and look forward to the opportunities for even closer collaboration with the city’s world-class science, academic and healthcare institutions,” says CEO Emma Walmsley.